SouthState Corp’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.9M | Sell |
4,866
-311
| -6% | -$131K | 0.08% | 158 |
|
|
2026
Q1 | $2.45M | Sell |
5,177
-448
| -8% | -$226K | 0.11% | 136 |
|
|
2025
Q4 | $2.63M | Sell |
5,625
-122
| -2% | -$56.6K | 0.12% | 126 |
|
|
2025
Q3 | $2.45M | Sell |
5,747
-248
| -4% | -$96.1K | 0.11% | 135 |
|
|
2025
Q2 | $2.3M | Sell |
5,995
-823
| -12% | -$297K | 0.1% | 140 |
|
|
2025
Q1 | $2.36M | Buy |
6,818
+3,040
| +80% | +$978K | 0.11% | 134 |
|
|
2024
Q4 | $1.13M | Buy |
3,778
+3,490
| +1,212% | +$1.22M | 0.07% | 139 |
|
|
2024
Q3 | $117K | Sell |
288
-7
| -2% | -$2.56K | 0.01% | 289 |
|
|
2024
Q2 | $94.8K | Sell |
295
-191
| -39% | -$62.1K | 0.01% | 317 |
|
|
2024
Q1 | $162K | Hold |
486
| – | – | 0.01% | 264 |
|
|
2023
Q4 | $132K | Sell |
486
-63
| -11% | -$15.6K | 0.01% | 268 |
|
|
2023
Q3 | $135K | Sell |
549
-10
| -2% | -$2.74K | 0.01% | 263 |
|
|
2023
Q2 | $170K | Sell |
559
-83
| -13% | -$23.1K | 0.02% | 249 |
|
|
2023
Q1 | $169K | Buy |
642
+41
| +7% | +$10.4K | 0.02% | 263 |
|
|
2022
Q4 | $144K | Buy |
601
+10
| +2% | +$2.24K | 0.01% | 293 |
|
|
2022
Q3 | $109K | Sell |
591
-135
| -19% | -$26.9K | 0.01% | 306 |
|
|
2022
Q2 | $122K | Buy |
726
+126
| +21% | +$27.1K | 0.01% | 301 |
|
|
2022
Q1 | $150K | Hold |
600
| – | – | 0.01% | 306 |
|
|
2021
Q4 | $154K | Sell |
600
-158
| -21% | -$38.7K | 0.01% | 290 |
|
|
2021
Q3 | $184K | Sell |
758
-59
| -7% | -$14.4K | 0.02% | 255 |
|
|
2021
Q2 | $169K | Sell |
817
-142
| -15% | -$28.9K | 0.01% | 257 |
|
|
2021
Q1 | $181K | Buy |
959
+59
| +7% | +$10.4K | 0.02% | 249 |
|
|
2020
Q4 | $148K | Sell |
900
-275
| -23% | -$40.2K | 0.01% | 248 |
|
|
2020
Q3 | $147K | Buy |
+1,175
| New | +$145K | 0.02% | 240 |
|
|
2019
Q2 | – | Sell |
-2,060
| Closed | -$269K | – | 265 |
|
|
2019
Q1 | $269K | Buy |
+2,060
| New | +$277K | 0.03% | 238 |
|
|
2018
Q1 | – | Sell |
-2,785
| Closed | -$245K | – | 266 |
|
|
2017
Q4 | $245K | Sell |
2,785
-3,756
| -57% | -$302K | 0.03% | 275 |
|
|
2017
Q3 | $522 | Buy |
6,541
+557
| +9% | +$44.8K | 0.06% | 172 |
|
|
2017
Q2 | $522K | Sell |
5,984
-1,171
| -16% | -$99.1K | 0.07% | 169 |
|
|
2017
Q1 | $637K | Buy |
+7,155
| New | +$597K | 0.08% | 161 |
|
|
2014
Q4 | – | Sell |
-5,428
| Closed | -$383K | – | 251 |
|
|
2014
Q3 | $383K | Buy |
+5,428
| New | +$359K | 0.06% | 196 |
|
Other funds holding HCA
SouthState Corp's HCA Position: Q2 2026 in Review
SouthState Corp reduced its HCA Healthcare (HCA) stake by 6% in Q2 2026, selling an estimated $131K and leaving 4,866 shares worth $1.9M. The position accounts for 0.08% of the portfolio, ranked #158.
SouthState Corp first reported a position in HCA in Q3 2014 and has held it in 30 quarters since. The position peaked at $2.63M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- SouthState Corp held 4,866 shares of HCA Healthcare worth $1.9M as of Q2 2026.
- SouthState Corp sold 311 HCA Healthcare shares in Q2 2026, an estimated $131K.
- HCA Healthcare made up 0.08% of SouthState Corp's portfolio in Q2 2026, its #158 holding.
- SouthState Corp first reported a position in HCA Healthcare in Q3 2014 and has held it in 30 quarters since.
- SouthState Corp's HCA Healthcare position peaked at $2.63M in Q4 2025.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.